Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 22, 2021
Total Value: $2.874B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 11,284,280 | $804M | 28.0% | $10.98 | +465.4% | SHS | G72800108 |
| — | MORPHIC HLDG INC | 3,951,566 | $224M | 7.8% | $29.75 | — | COM | 61775R105 |
| ANAB | ANAPTYSBIO INC | 7,521,024 | $204M | 7.1% | $23.15 | +9.6% | COM | 032724106 |
| RCUS | ARCUS BIOSCIENCES INC | 5,122,359 | $179M | 6.2% | $27.85 | +11.7% | COM | 03969F109 |
| XNCR | XENCOR INC | 4,906,106 | $160M | 5.6% | $34.08 | -3.6% | COM | 98401F105 |
| NUVB | NUVATION BIO INC | 13,711,517 | $136M | 4.7% | $11.19 | -19.0% | COM CL A | 67080N101 |
| ALEC | ALECTOR INC | 4,994,970 | $114M | 4.0% | $20.12 | +39.2% | COM | 014442107 |
| — | MIRATI THERAPEUTICS INC | 464,298 | $82.14M | 2.9% | $97.40 | — | COM | 60468T105 |
| GLPG | GALAPAGOS NV | 1,558,749 | $82.01M | 2.9% | $52.61 | — | SPON ADR | 36315X101 |
| STTK | SHATTUCK LABS INC | 3,709,072 | $75.59M | 2.6% | $30.34 | -29.5% | COM | 82024L103 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,468,944 | $72.54M | 2.5% | $30.24 | -33.0% | COM | 68622P109 |
| KURA | KURA ONCOLOGY INC | 3,724,437 | $69.76M | 2.4% | $22.14 | -14.9% | COM | 50127T109 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,759,505 | $67.97M | 2.4% | $27.15 | -19.9% | COM | 05370A108 |
| — | GRITSTONE BIO INC | 5,560,748 | $60.06M | 2.1% | $6.58 | — | COM | 39868T105 |
| RLAY | RELAY THERAPEUTICS INC | 1,385,276 | $43.68M | 1.5% | $37.18 | -9.5% | COM | 75943R102 |
| — | ITEOS THERAPEUTICS INC | 1,303,157 | $35.19M | 1.2% | $25.73 | — | COM | 46565G104 |
| NRIX | NURIX THERAPEUTICS INC | 1,126,640 | $33.75M | 1.2% | $29.56 | +4.4% | COM | 67080M103 |
| JANX | JANUX THERAPEUTICS INC | 1,411,975 | $30.54M | 1.1% | $22.27 | +29.2% | COM | 47103J105 |
| DSGN | DESIGN THERAPEUTICS INC | 1,863,098 | $27.37M | 1.0% | $26.06 | -36.2% | COM | 25056L103 |
| — | BLUEPRINT MEDICINES CORP | 250,000 | $25.93M | 0.9% | — | — | Call | 09627Y109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,443,800 | $25.58M | 0.9% | $42.63 | 0.0% | COM | 74366E102 |
| — | DICERNA PHARMACEUTICALS INC | 1,249,812 | $25.2M | 0.9% | $20.16 | — | COM | 253031108 |
| — | AKOUOS INC | 1,975,984 | $22.94M | 0.8% | $22.50 | — | COM | 00973J101 |
| — | SOLID BIOSCIENCES INC | 9,202,702 | $21.99M | 0.8% | $7.31 | — | COM | 83422E105 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,279,175 | $21.23M | 0.7% | $31.81 | -43.1% | COM | 28036F105 |
| OVID | OVID THERAPEUTICS INC | 6,082,200 | $20.44M | 0.7% | $3.32 | +9.8% | COM | 690469101 |
| TNGX | TANGO THERAPEUTICS INC | 1,300,000 | $16.81M | 0.6% | $11.99 | 0.0% | COM ADDED | 87583X109 |
| — | BLUEBIRD BIO INC | 802,507 | $15.34M | 0.5% | $19.11 | — | COM | 09609G100 |
| ERAS | ERASCA INC | 700,000 | $14.85M | 0.5% | $20.63 | 0.0% | COM ADDED | 29479A108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 754,545 | $12.6M | 0.4% | $22.21 | — | SPONSORED ADS | 152309100 |
| SPRY | SILVERBACK THERAPEUTICS INC | 1,184,710 | $11.82M | 0.4% | $33.36 | -26.1% | COM | 82835W108 |
| — | ODONATE THERAPEUTICS INC | 3,727,261 | $10.85M | 0.4% | $3.04 | — | COM | 676079106 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,081,077 | $10.07M | 0.4% | $2.75 | +7.5% | COM | 221015100 |
| IMVT | IMMUNOVANT INC | 1,140,819 | $9.914M | 0.3% | $9.02 | 0.0% | COM | 45258J102 |
| — | NUVATION BIO INC | 963,333 | $9.576M | 0.3% | $10.45 | — | *W EXP 07/07/202 | 67080N119 |
| CCCC | C4 THERAPEUTICS INC | 200,000 | $8.936M | 0.3% | $29.00 | +47.7% | COM STK | 12529R107 |
| — | KRONOS BIO INC | 387,357 | $8.119M | 0.3% | $29.87 | — | COM | 50107A104 |
| — | NEOLEUKIN THERAPEUTICS INC | 860,619 | $6.222M | 0.2% | $7.28 | — | COM | 64049K104 |
| — | FRAZIER LIFESCIENCES ACQU CO | 587,615 | $5.77M | 0.2% | $9.80 | — | SHS | G3710A105 |
| ACIU | AC IMMUNE SA | 751,251 | $5.041M | 0.2% | $5.79 | +23.6% | SHS | H00263105 |
| — | NGM BIOPHARMACEUTICALS INC | 245,000 | $5M | 0.2% | $30.29 | — | Call | 62921N105 |
| — | CYCLERION THERAPEUTICS INC | 1,606,276 | $4.931M | 0.2% | $5.17 | — | COM | 23255M105 |
| — | JIYA ACQUISITION CORP | 500,000 | $4.875M | 0.2% | $10.30 | — | COM CL A | 47760M102 |
| — | VERVE THERAPEUTICS INC | 100,000 | $4.7M | 0.2% | $60.25 | — | COM | 92539P101 |
| — | KINNATE BIOPHARMA INC | 175,000 | $4.029M | 0.1% | $25.42 | — | COM | 49705R105 |
| — | HEALTH SCIENCES ACQ CORP 2 ORD | 400,000 | $3.956M | 0.1% | $11.00 | — | SHS | G4411D109 |
| — | FS DEVELOPMENT CORP II | 371,014 | $3.692M | 0.1% | $9.95 | — | COM CL A | 30318F100 |
| DYN | DYNE THERAPEUTICS INC | 215,000 | $3.569M | 0.1% | $21.96 | -19.3% | COM | 26818M108 |
| — | IGM BIOSCIENCES INC | 38,030 | $2.501M | 0.1% | $83.20 | — | COM | 449585108 |
| — | FORMA THERAPEUTICS HLDGS INC | 90,141 | $2.09M | 0.1% | $24.89 | — | SHS | 34633R104 |
| — | BCLS ACQUISITION CORP | 200,000 | $1.992M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| MLTX | HELIX ACQUISITION CORP | 200,000 | $1.99M | 0.1% | $11.37 | — | COM CL A | G4444C102 |
| — | 5 01 ACQUISITION CORP | 200,000 | $1.964M | 0.1% | $10.17 | — | COM CL A | 33836P105 |
| — | EUCRATES BIOMEDICAL ACQU COR | 200,000 | $1.956M | 0.1% | $9.98 | — | SHS | G3141W106 |
| — | BOLT BIOTHERAPEUTICS INC | 150,000 | $1.848M | 0.1% | $32.91 | — | COM | 097702104 |
| CRBU | CARIBOU BIOSCIENCES INC | 75,000 | $1.79M | 0.1% | $24.45 | 0.0% | COM ADDED | 142038108 |
| — | ARYA SCIENCES ACQU CORP IV | 150,000 | $1.508M | 0.1% | $10.47 | — | CL A | G31659108 |
| PMVP | PMV PHARMACEUTICALS INC | 50,000 | $1.49M | 0.1% | $36.80 | -13.2% | COM | 69353Y103 |
| BCAB | BIOATLA INC | 50,000 | $1.472M | 0.1% | $33.43 | +16.6% | COM | 09077B104 |
| — | REPARE THERAPEUTICS INC | 50,000 | $1.286M | 0.0% | $31.02 | — | COM | 760273102 |
| MGTX | MEIRAGTX HLDGS PLC | 94,819 | $1.25M | 0.0% | $16.89 | -18.9% | COM | G59665102 |
| VYGR | VOYAGER THERAPEUTICS INC | 445,992 | $1.173M | 0.0% | $2.63 | — | COM | 92915B106 |
| — | CAREMAX INC | 100,000 | $986K | 0.0% | $12.90 | — | *W EXP 06/08/202 | 14171W111 |
| — | TURMERIC ACQUISITION CORP | 100,000 | $979K | 0.0% | $9.77 | — | CL A | G9127T108 |
| — | FRAZIER LIFESCIENCES ACQU CO | 66,665 | $655K | 0.0% | $9.77 | — | *W EXP 11/30/202 | G3710A113 |
| — | EUCRATES BIOMEDICAL ACQU COR | 66,666 | $652K | 0.0% | $9.98 | — | *W EXP 10/23/202 | G3141W122 |
| — | OMEGA ALPHA SPAC | 50,000 | $487K | 0.0% | $9.90 | — | CL A | G6749V107 |
| SRZNW | SURROZEN INC | 66,665 | $471K | 0.0% | $7.07 | — | *W EXP 10/28/2025 | 86889P117 |
| — | TURMERIC ACQUISITION CORP | 33,333 | $326K | 0.0% | $9.78 | — | *W EXP 10/08/202 | G9127T124 |
| SRRK | SCHOLAR ROCK HLDG CORP | 8,208 | $271K | 0.0% | $35.00 | 0.0% | COM | 80706P103 |
| — | ALPINE IMMUNE SCIENCES INC | 7,001 | $75,000 | 0.0% | $8.79 | — | COM | 02083G100 |